TENAGRITY SOLUTIONS, LLC for CENTER FOR ADDICTION SCIENCE, POLICY, AND RESEARCH
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD; potential legislation to create a SUD PRV to increase development of and access to new SUD medicines; support for the FDA Commissioners national PRV and related pathways; support for NIH high-impact clinical trials evaluating repuposed off-patent therapeutics and widely used supplements with potential CMMI involvement; support for White House and CMMI exploration of non-opioid acute pain therapeutics. Related language requests in FY27 L-HHS and Ag-FDA appropriations. Related potential legislation (discussions particularly with Rep. Cline, Auchincloss, and Harder).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNY CAROLINE DEBERRY | Senior Legislative Assistant/ Legislative Assistant, Congressman John J. Duncan, Jr.; Senior Campaign Finance Analyst/ Campaign Finance Analyst, Federal Election Commission |
Alcohol and Drug Abuse ALC
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD; potential legislation to create a SUD PRV to increase development of and access to new SUD medicines; support for the FDA Commissioners national PRV and related pathways; support for NIH high-impact clinical trials evaluating repuposed off-patent therapeutics and widely used supplements with potential CMMI involvement; support for White House and CMMI exploration of non-opioid acute pain therapeutics. Related language requests in FY27 L-HHS and Ag-FDA appropriations. Related potential legislation (discussions particularly with Rep. Cline, Auchincloss, and Harder).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNY CAROLINE DEBERRY | Senior Legislative Assistant/ Legislative Assistant, Congressman John J. Duncan, Jr.; Senior Campaign Finance Analyst/ Campaign Finance Analyst, Federal Election Commission |
Budget/Appropriations BUD
Discussions with / outreach to (and/or preparation for such outreach) Congressional offices and HHS officials re: potential avenues to increase GLP-1 access as a method of substance use disorder (SUD) treatment and other potential strategies for increasing innovation and the development of improved addiction medicines; FDA reforms including modernized endpoints for SUD; potential legislation to create a SUD PRV to increase development of and access to new SUD medicines; support for the FDA Commissioners national PRV and related pathways; support for NIH high-impact clinical trials evaluating repuposed off-patent therapeutics and widely used supplements with potential CMMI involvement; support for White House and CMMI exploration of non-opioid acute pain therapeutics. Related language requests in FY27 L-HHS and Ag-FDA appropriations. Related potential legislation (discussions particularly with Rep. Cline, Auchincloss, and Harder).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNY CAROLINE DEBERRY | Senior Legislative Assistant/ Legislative Assistant, Congressman John J. Duncan, Jr.; Senior Campaign Finance Analyst/ Campaign Finance Analyst, Federal Election Commission |
Commodities (big ticket) CDT
Support for HR7840 (Event Contract Enforcement Act) addressing event contracts on war, etc. (recognizing such activity as gambling, a common addictive activity).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNY CAROLINE DEBERRY | Senior Legislative Assistant/ Legislative Assistant, Congressman John J. Duncan, Jr.; Senior Campaign Finance Analyst/ Campaign Finance Analyst, Federal Election Commission |
Gaming/Gambling/Casino GAM
Support for HR7840 (Event Contract Enforcement Act) addressing event contracts on war, etc. (recognizing such activity as gambling, a common addictive activity).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNY CAROLINE DEBERRY | Senior Legislative Assistant/ Legislative Assistant, Congressman John J. Duncan, Jr.; Senior Campaign Finance Analyst/ Campaign Finance Analyst, Federal Election Commission |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.